Mirtazapine Use in Elderly Patients with Major Depression

Dosing and Administration

The American Geriatrics Society recommends starting mirtazapine at a low dose of 7.5-15 mg daily, with dose escalation employing small increments and at least one week of observation at each dose level before advancing 1

Elderly patients are at risk of sedation and somnolence, occurring in approximately 23% of patients, and require close monitoring 2, 3
Orthostatic hypotension is a concern due to histamine H1 receptor and peripheral α1-adrenergic receptor blockade, increasing fall risk 1, 2

Mirtazapine's side effect profile can be therapeutically beneficial in specific elderly populations, including weight gain and appetite stimulation, which can benefit elderly patients with anorexia, weight loss, or dementia-related depression 2
The American Geriatrics Society notes that mirtazapine has favorable cardiovascular safety, lacking the cardiac conduction effects of tricyclic antidepressants 2, 1
Mirtazapine has minimal anticholinergic effects compared to tricyclic antidepressants, reducing risks of urinary retention, constipation, and cognitive impairment 1, 2

Regular monitoring is essential when initiating or maintaining mirtazapine in elderly patients, including monitoring for neuropsychiatric side effects, orthostatic vital sign changes, serum sodium levels, and weight changes 3, 2
Gradual dose reduction is recommended when stopping mirtazapine to minimize the risk of discontinuation syndrome, particularly in elderly patients who may be more sensitive to withdrawal effects 1

The American Geriatrics Society recommends considering drug-drug interactions in the context of polypharmacy common in elderly patients, as decreased clearance is expected with aging 4